{
  "abstract": "Cardiovascular involvement in Marfan syndrome (MFS) was long considered to be limited to the thoracic aorta. For decades, the attention of clinicians and researchers has focused primarily on aortic root dilatation and the risk of acute aortic dissection; complications that historically determined patient survival. This focus has led to major advances, including improvements and standardisation of prophylactic surgical techniques, widespread implementation of echocardiographic follow-up, development of beta-blocker therapy and the establishment of structured international guidelines.1 However, as patient survival improves, another reality is progressively emerging: MFS is not merely a disease of the aorta but rather a diffuse systemic arteriopathy.",
  "authors": [
    {
      "affiliations": [
        "Swiss Medical Network, Genolier, Switzerland",
        "Referral Centre for Marfan Disease, Hôpital Bichat Claude-Bernard, Paris, France"
      ],
      "name": "Quentin Pellenc"
    }
  ],
  "title": "Beyond the aorta: Marfan syndrome as a diffuse arteriopathy",
  "uid": "7af64293-e870-515f-90fb-b8cc9f005dea"
}